Chatchawin Assanasen, M.D.

Professor of Pediatrics
Children’s Cancer Research
Institute Distinguished Chair in Pediatric Oncology
Division of Hematology-Oncology

M.D., Medicine, St. George’s University, School of Medicine, Bay Shore, NY, 1996
BA, Natural Science , University of Pennsylvania, Philadelphia, PA, 1990

Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX, 2000-03

Pediatric, University of Florida College of Medicine Health Science Center, Jacksonville, FL, 1996-1999

Pediatrics, 1999; Hematology-Oncology, 2009

Recent Publications:
Ranch D, Crowther B, Arar M, Assanasen C. 2014 Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation. Pediatric Transplant Sep;18(6):E185-9.

Amin R, Bohnert A, Holmes L, Rajasekaran A, Assanasen C. Response to “Childhood clustering in Florida: weighing the evidence”. Pediatric Blood Cancer 2010 Jul;54(7):1053-1053.

Amin R, Bohnert A, Holmes L, Rajasekaran A, Assanasen C. Epidemiologic mapping of Florida childhood cancer clusters (Cover Page) Pediatric Blood Cancer 2010 Apr;54(4):511-518.

Kreiger PA, Judkins AR, Russo PA, Biegel JA, Lestini BJ, Assanasen C, Pawel BR. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas. Mod Pathol 2009 Jan;22(1):142-150.

Fine RL, Shah SS, Moulton TA, Yu IR, Fogelman DR, Richardson M, Burris HA, Samuels BL, Assanasen C, Gorroochurn P, Hibshoosh H, Orjuela M, Garvin J, Goldman FD, Dubovsky D, Walterhouse D, Halligan G. Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy. Cancer Chemother Pharmacol 2007 Mar;59(4):429-437.

Assanasen C, Mineo C, Seetharam D, Yuhanna IS, Marcel YL, Connelly MA, Williams DL, de la Llera-Moya M, Shaul PW, Silver DL. Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J Clin Invest 2005 Apr;115(4):969-977.